Clarification on Lumico’s Underwriting Process
It has been mentioned by several agents that during the underwriting process Milliman RX Rules has been making underwriting decisions, based on the drugs they show for an individual applying for Lumico’s medicare supplement plans. We believe this is happening because when a client is declined due to a particular drug or combination of drugs we suggest the applicant contact Milliman to see and confirm the drugs they have listed are actually correct. The results received from Milliman are then reviewed by Lumico for a underwriting decision. Milliman in no way makes these underwriting decisions but simply provides Lumico with the information on drugs that have been prescribed to the applicant. If clients believe that information on their pharmacy report is not correct, they can work with Milliman to dispute the information and ask for a correction. All of us that have written medicare supplements know how important the drug history is to all companies in this market place. We hope this brings a clearer understanding of Lumico’s process and to insure you that Lumico makes all underwriting decisions!
We wish all of our representatives a successful remainder of the third quarter and look forward to everyone having a huge AEP season!!!